Search research articles
Contact Us
Filters
Showing results (21-30 of 142) with videos related to
Page
of 15
Sort By:
The Journal of Pharmacy and Pharmacology
|
February 3, 2006
Synthesis and binding profile of constrained analogues of N-[4-(4-arylpiperazin-1-yl)butyl]-3-methoxybenzamides, a class of potent dopamine D3 receptor ligands
Marcello Leopoldo, Enza Lacivita, Nicola A Colabufo, et al.
Chemmedchem
|
November 1, 2013
PET radiotracers for imaging P-glycoprotein: the challenge for early diagnosis in AD
Marcello Leopoldo, Marialessandra Contino, Francesco Berardi, et al.
Pharmacology & Therapeutics
|
October 7, 2010
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders
Marcello Leopoldo, Enza Lacivita, Francesco Berardi, et al.
Bioorganic & Medicinal Chemistry
|
January 6, 2009
Determination of 1-aryl-4-propylpiperazine pKa values: the substituent on aryl modulates basicity
Enza Lacivita, Marcello Leopoldo, Paola De Giorgio, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Multi-Target Directed Ligands (MTDLs) Binding the σ<sub>1</sub> Receptor as Promising Therapeutics: State of the Art and Perspectives
Francesca Serena Abatematteo, Mauro Niso, Marialessandra Contino, et al.
Frontiers in Behavioral Neuroscience
|
March 28, 2015
Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome
Lara Costa, Lara M Sardone, Enza Lacivita, et al.
Current Pharmaceutical Design
|
August 13, 2016
Design and Synthesis of New Selective P-gp Substrates and Inhibitors
Mariangela Cantore, Marcello Leopoldo, Francesco Berardi, et al.
Current Neuropharmacology
|
September 14, 2022
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation
Ewa Trojan, Monika Leśkiewicz, Enza Lacivita, et al.
Antioxidants (Basel, Switzerland)
|
January 28, 2026
Beyond Radical Scavengers: Focus on NADPH Oxidases (NOX) Inhibitors as New Agents for Antioxidant Therapy in Alzheimer's Disease
Leonardo Brunetti, Fabio Francavilla, Angela Santo, et al.
Neuropharmacology
|
September 28, 2011
Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice
Walter Adriani, Domenica Travaglini, Enza Lacivita, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 142) with videos related to
Sort By:
Page
of 15
The Journal of Pharmacy and Pharmacology
|
February 3, 2006
Synthesis and binding profile of constrained analogues of N-[4-(4-arylpiperazin-1-yl)butyl]-3-methoxybenzamides, a class of potent dopamine D3 receptor ligands
Marcello Leopoldo, Enza Lacivita, Nicola A Colabufo, et al.
Chemmedchem
|
November 1, 2013
PET radiotracers for imaging P-glycoprotein: the challenge for early diagnosis in AD
Marcello Leopoldo, Marialessandra Contino, Francesco Berardi, et al.
Pharmacology & Therapeutics
|
October 7, 2010
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders
Marcello Leopoldo, Enza Lacivita, Francesco Berardi, et al.
Bioorganic & Medicinal Chemistry
|
January 6, 2009
Determination of 1-aryl-4-propylpiperazine pKa values: the substituent on aryl modulates basicity
Enza Lacivita, Marcello Leopoldo, Paola De Giorgio, et al.
International Journal of Molecular Sciences
|
July 2, 2021
Multi-Target Directed Ligands (MTDLs) Binding the σ<sub>1</sub> Receptor as Promising Therapeutics: State of the Art and Perspectives
Francesca Serena Abatematteo, Mauro Niso, Marialessandra Contino, et al.
Frontiers in Behavioral Neuroscience
|
March 28, 2015
Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome
Lara Costa, Lara M Sardone, Enza Lacivita, et al.
Current Pharmaceutical Design
|
August 13, 2016
Design and Synthesis of New Selective P-gp Substrates and Inhibitors
Mariangela Cantore, Marcello Leopoldo, Francesco Berardi, et al.
Current Neuropharmacology
|
September 14, 2022
The Formyl Peptide Receptor 2 as a Target for Promotion of Resolution of Inflammation
Ewa Trojan, Monika Leśkiewicz, Enza Lacivita, et al.
Antioxidants (Basel, Switzerland)
|
January 28, 2026
Beyond Radical Scavengers: Focus on NADPH Oxidases (NOX) Inhibitors as New Agents for Antioxidant Therapy in Alzheimer's Disease
Leonardo Brunetti, Fabio Francavilla, Angela Santo, et al.
Neuropharmacology
|
September 28, 2011
Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice
Walter Adriani, Domenica Travaglini, Enza Lacivita, et al.
Page
of 15